FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386324995> ?p ?o ?g. }

• W4386324995 endingPage "6379" @default.
• W4386324995 startingPage "6379" @default.
• W4386324995 abstract "Human soluble epoxide hydrolase (sEH), a dual-functioning homodimeric enzyme with hydrolase and phosphatase activities, is known for its pivotal role in the hydrolysis of epoxyeicosatrienoic acids. Inhibitors targeting sEH have shown promising potential in the treatment of various life-threatening diseases. In this study, we employed a range of in silico modeling approaches to investigate a diverse dataset of structurally distinct sEH inhibitors. Our primary aim was to develop predictive and validated models while gaining insights into the structural requirements necessary for achieving higher inhibitory potential. To accomplish this, we initially calculated molecular descriptors using nine different descriptor-calculating tools, coupled with stochastic and non-stochastic feature selection strategies, to identify the most statistically significant linear 2D-QSAR model. The resulting model highlighted the critical roles played by topological characteristics, 2D pharmacophore features, and specific physicochemical properties in enhancing inhibitory potential. In addition to conventional 2D-QSAR modeling, we implemented the Transformer-CNN methodology to develop QSAR models, enabling us to obtain structural interpretations based on the Layer-wise Relevance Propagation (LRP) algorithm. Moreover, a comprehensive 3D-QSAR analysis provided additional insights into the structural requirements of these compounds as potent sEH inhibitors. To validate the findings from the QSAR modeling studies, we performed molecular dynamics (MD) simulations using selected compounds from the dataset. The simulation results offered crucial insights into receptor–ligand interactions, supporting the predictions obtained from the QSAR models. Collectively, our work serves as an essential guideline for the rational design of novel sEH inhibitors with enhanced therapeutic potential. Importantly, all the in silico studies were performed using open-access tools to ensure reproducibility and accessibility." @default.
• W4386324995 created "2023-09-01" @default.
• W4386324995 creator A5029780671 @default.
• W4386324995 creator A5031384822 @default.
• W4386324995 creator A5031900984 @default.
• W4386324995 creator A5033927225 @default.
• W4386324995 creator A5045797458 @default.
• W4386324995 creator A5049099778 @default.
• W4386324995 creator A5091008040 @default.
• W4386324995 date "2023-08-31" @default.
• W4386324995 modified "2023-09-27" @default.
• W4386324995 title "In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design" @default.
• W4386324995 cites W1545231783 @default.
• W4386324995 cites W1989922595 @default.
• W4386324995 cites W1990399577 @default.
• W4386324995 cites W2011877643 @default.
• W4386324995 cites W2022006134 @default.
• W4386324995 cites W2022400681 @default.
• W4386324995 cites W2023782921 @default.
• W4386324995 cites W2028521503 @default.
• W4386324995 cites W2041345281 @default.
• W4386324995 cites W2043906184 @default.
• W4386324995 cites W2054716083 @default.
• W4386324995 cites W2055776987 @default.
• W4386324995 cites W2059713851 @default.
• W4386324995 cites W2061937956 @default.
• W4386324995 cites W2068950612 @default.
• W4386324995 cites W2075808059 @default.
• W4386324995 cites W2080027925 @default.
• W4386324995 cites W2080700226 @default.
• W4386324995 cites W2087347434 @default.
• W4386324995 cites W2087661061 @default.
• W4386324995 cites W2104900375 @default.
• W4386324995 cites W2105668062 @default.
• W4386324995 cites W2142138587 @default.
• W4386324995 cites W2144006306 @default.
• W4386324995 cites W2146083192 @default.
• W4386324995 cites W2164875713 @default.
• W4386324995 cites W2166396390 @default.
• W4386324995 cites W2167982865 @default.
• W4386324995 cites W2169678694 @default.
• W4386324995 cites W2198264407 @default.
• W4386324995 cites W2200017991 @default.
• W4386324995 cites W2271048273 @default.
• W4386324995 cites W2336452334 @default.
• W4386324995 cites W2398789413 @default.
• W4386324995 cites W2405112318 @default.
• W4386324995 cites W2723007231 @default.
• W4386324995 cites W2747416722 @default.
• W4386324995 cites W2750477650 @default.
• W4386324995 cites W2791355014 @default.
• W4386324995 cites W2799568897 @default.
• W4386324995 cites W2901719664 @default.
• W4386324995 cites W2911964244 @default.
• W4386324995 cites W2922496237 @default.
• W4386324995 cites W2953632797 @default.
• W4386324995 cites W2971033395 @default.
• W4386324995 cites W2979820174 @default.
• W4386324995 cites W3023042104 @default.
• W4386324995 cites W3030978062 @default.
• W4386324995 cites W3110719286 @default.
• W4386324995 cites W3174695796 @default.
• W4386324995 cites W3203035680 @default.
• W4386324995 cites W3212057318 @default.
• W4386324995 cites W3217486495 @default.
• W4386324995 cites W4200473704 @default.
• W4386324995 cites W4223503791 @default.
• W4386324995 cites W4282053678 @default.
• W4386324995 cites W4297153952 @default.
• W4386324995 cites W4308795837 @default.
• W4386324995 cites W4311025597 @default.
• W4386324995 cites W911658671 @default.
• W4386324995 doi "https://doi.org/10.3390/molecules28176379" @default.
• W4386324995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37687207" @default.
• W4386324995 hasPublicationYear "2023" @default.
• W4386324995 type Work @default.
• W4386324995 citedByCount "0" @default.
• W4386324995 crossrefType "journal-article" @default.
• W4386324995 hasAuthorship W4386324995A5029780671 @default.
• W4386324995 hasAuthorship W4386324995A5031384822 @default.
• W4386324995 hasAuthorship W4386324995A5031900984 @default.
• W4386324995 hasAuthorship W4386324995A5033927225 @default.
• W4386324995 hasAuthorship W4386324995A5045797458 @default.
• W4386324995 hasAuthorship W4386324995A5049099778 @default.
• W4386324995 hasAuthorship W4386324995A5091008040 @default.
• W4386324995 hasBestOaLocation W43863249951 @default.
• W4386324995 hasConcept C104317684 @default.
• W4386324995 hasConcept C119857082 @default.
• W4386324995 hasConcept C164126121 @default.
• W4386324995 hasConcept C181199279 @default.
• W4386324995 hasConcept C185592680 @default.
• W4386324995 hasConcept C18605011 @default.
• W4386324995 hasConcept C2775905019 @default.
• W4386324995 hasConcept C41008148 @default.
• W4386324995 hasConcept C55493867 @default.
• W4386324995 hasConcept C56173144 @default.
• W4386324995 hasConcept C70721500 @default.
• W4386324995 hasConcept C71240020 @default.

• next